Trxade Health Inc
MEDS
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.28M
Close$
$-9.43
224.2% downside
Current Fair Value
224.2% downsideOvervalued by 224.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.28 Million |
|---|---|
| Enterprise Value | $-3,519,467,045.00 |
| Dividend Yield | $9.50 (125.16%) |
| Earnings per Share | $-2.7 |
| Beta | 2.17 |
| Outstanding Shares | 406,308,150 |
Return
| Return on Equity | -67.21% |
|---|---|
| Return on Assets | -55.68% |
| Return on Invested Capital | -60.38% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | 0 |
| Price to Sales | 7.59 |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | -7.21 |
| Enterprise Value to EBIT | 0.07 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 12, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data